Privalle C T, McNamara B C, Dhariwal M S, Jefcoate C R
Department of Pharmacology, University of Wisconsin Medical School, Madison 53706.
Mol Cell Endocrinol. 1987 Sep;53(1-2):87-101. doi: 10.1016/0303-7207(87)90195-x.
Rat adrenal mitochondria exhibit a linear 2-fold accumulation of cholesterol for 20 min following either in vivo ether stress or ACTH administration, providing cholesterol metabolism is inhibited by aminoglutethimide (AMG). Additional cycloheximide (CX) pretreatment only slightly decreases this increase, but the location of accumulation shifts from the inner membrane to the outer membrane, implying a decreased cholesterol transfer from outer to inner membrane. Although the capacity of outer mitochondrial membranes was saturated after a 10-min treatment with CX, a 20-min treatment resulted in further retention of cholesterol in intact mitochondria that was not recovered in the isolated membranes. An additional pool of loosely bound cholesterol is proposed for CX mitochondria. These studies provide evidence that the CX-sensitive step of adrenal steroidogenesis attributed to loss of a labile ACTH regulatory protein (Pedersen, R.C. and Brownie, A.C. (1983) Proc. Natl. Acad. Sci. U.S.A. 80, 1882-1886) involves cholesterol transfer from the outer to the inner mitochondrial membrane. ACTH also enhances the PI and PE content of the outer membranes by a CX-sensitive mechanism that may contribute to intramitochondrial cholesterol transport. CX treatment does not affect cholesterol uptake by the inner membrane from phospholipid vesicles. The initial rate of endogenous metabolism in isolated inner membranes is insensitive to pretreatment (2 nmol/nmol P-450/min). The duration of this linear rate was increased 4-fold by AMG treatment while this increase was prevented by CX treatment. The kinetics indicate differences in inner membrane reactive cholesterol levels. Inner membranes also contained a fraction of unreactive cholesterol that is insensitive to pretreatment. Cholesterol-P-450scc complex formation for all pretreatments fits a single hyperbolic function of the reactive cholesterol content of the inner mitochondrial membrane (Kd = 0.025 mol cholesterol/mol phospholipid), and is activated over 5-fold upon mitochondrial disruption. All changes in inner membranes caused by CX can, therefore, be attributed solely to the restricted cholesterol access in vivo.
大鼠肾上腺线粒体在体内乙醚应激或促肾上腺皮质激素(ACTH)给药后20分钟内呈现胆固醇线性2倍积累,前提是胆固醇代谢被氨鲁米特(AMG)抑制。额外的放线菌酮(CX)预处理仅略微降低这种增加,但积累位置从内膜转移到外膜,这意味着胆固醇从外膜向内膜的转移减少。尽管用CX处理10分钟后外线粒体膜的容量已饱和,但20分钟的处理导致完整线粒体中胆固醇进一步滞留,而在分离的膜中未恢复。有人提出CX处理的线粒体存在一个额外的松散结合胆固醇池。这些研究提供了证据,表明肾上腺类固醇生成中CX敏感步骤归因于不稳定ACTH调节蛋白的丧失(Pedersen,R.C.和Brownie,A.C.(1983年)美国国家科学院院刊80,1882 - 1886),涉及胆固醇从外线粒体膜向内线粒体膜的转移。ACTH还通过一种CX敏感机制增强外膜的磷脂酰肌醇(PI)和磷脂酰乙醇胺(PE)含量,这可能有助于线粒体内胆固醇运输。CX处理不影响内膜从磷脂囊泡摄取胆固醇。分离内膜中内源性代谢的初始速率对预处理不敏感(2 nmol/nmol P - 450/分钟)。AMG处理使这种线性速率的持续时间增加了4倍,而CX处理阻止了这种增加。动力学表明内膜反应性胆固醇水平存在差异。内膜还含有一部分对预处理不敏感的非反应性胆固醇。所有预处理的胆固醇 - 细胞色素P450侧链裂解酶(P - 450scc)复合物形成符合内线粒体膜反应性胆固醇含量的单一双曲线函数(Kd = 0.025摩尔胆固醇/摩尔磷脂),并且在线粒体破坏后被激活超过5倍。因此,CX引起的内膜所有变化都可仅归因于体内胆固醇获取受限。